Asterias Biotherapeutics, Inc. was a biotechnology company developing cell therapy programs based on immunotherapy and pluripotent stem cell platform technologies for oncology and neurology.
Amount not specifiedReported1Asterias Biotherapeutics Announces Positive Efficacy Data in Patients with Complete Cervical Spinal Cord Injuries Treated with AST-OPC1asteriasbiotherapeutics.com
Function or object indicated by the source: « the Phase 1/2a clinical trial and other product development activities for AST-OPC1 ».
Reported1Asterias Biotherapeutics Announces Positive Efficacy Data in Patients with Complete Cervical Spinal Cord Injuries Treated with AST-OPC1asteriasbiotherapeutics.com
Position or object indicated by the source: « AST-VAC2 ».
Sources
1.
Asterias Biotherapeutics Announces Positive Efficacy Data in Patients with Complete Cervical Spinal Cord Injuries Treated with AST-OPC1